Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

6,8-bis(benzylthio)octanoic acid

EU orphan designation number: EU/3/18/2105   
Active ingredient: 6,8-bis(benzylthio)octanoic acid
Indication: Treatment of pancreatic cancer
Sponsor: IQVIA RDS Ireland Limited
Estuary House, East Point Business Park, Fairview, Dublin 3, DO3 Y6A2, Ireland

  

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/12/2018 Orphan designation EMA/OD/167/18 (2018)9020 of 14/12/2018